L-[1-13C] phenylalanine breath test reflects histological changes in the liver

Objective. Compared with healthy individuals, patients with chronic liver disease reportedly have lower L-[1-C-13] phenylalanine breath test (PBT) values. However, there is no report detailing the relationship between the results of PBT and pathological data in liver disease patients. This study was designed to investigate the degree of histological changes in the liver that induce PBT changes and the time of measurement that reflects the histological change. Materials and methods. PBT was performed in 47 patients (10 with a normal liver, and 37 with chronic hepatitis C). After administering 10 mg/kg L-[1-C-13] phenylalanine, 300 mL of expired air was collected over 90 min at 15-min intervals. The rate of hepatic phenylalanine oxidation (%C-13 dose h(-1)) at each time point was calculated from the amount of (CO2)-C-13 in the exhaled air, assuming a CO2 production rate of 300 mmol m(-2) body surface area per hour. Subsequently, we examined the relationship between the results of PBT and METAVIR pathological scoring. Results. The highest correlation coefficients between the fibrosis score and %13C dose h-1 and between the fibrosis score and %13C cumulative excretion were obtained at 45 min (r = -0.779, R-2 = 0.607; P < 0.0001) and 75 min (r = -0.768, R-2 = 0.590; P < 0.0001), respectively. Conclusion. PBT is a useful adjunct for detecting histological changes in the liver. The %13C dose h-1 value at 45 min and the %13C cumulative excretion value at 75 min of PBT are useful for detecting hepatic histological change. (C) 2003 Elsevier Inc. All rights reserved.